Forty years of topical beta-blockers

28 February 2020
Volume 21, Issue 1

This article reviews the use of topical beta-blockers for the treatment of glaucoma.

Although beta-blockers are no longer first choice for the treatment for glaucoma, they maintain a place in the treatment pathway. This article reviews the history and contemporary use of topical beta-blockers, and considers the range of alternative medical, laser and minimally invasive surgical options for glaucoma.

Sign in to continue

Forgotten password?
Register

Sign in to view the article

Not a member? Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.

Related further reading

This in-person peer review in Belfast is free of charge for College membersĀ and will cover your peer review CPD requirement, offering 3 CPD points.

Kathy Oxtoby looks at the intended and adverse effects of corticosteroids, the common concerns patients have, and how to manage a steroid response.

We have a number of therapeutic points available to IP members struggling to cover their competencies by the end of this year.